Showing results (1041-1050 of 1,506) with videos related to

Sort By:
Pageof 151
Antimicrobial Stewardship & Healthcare Epidemiology : ASHE|July 14, 2025
Temporal trends in vaccination and antibiotic use among young children in the United States, 2000-2019Amanda L Eiden, Qing Liu, Yoonyoung Choi, et al.
Journal of Neuropathology and Experimental Neurology|June 26, 2026
Primary intracranial sarcoma, DICER1-mutant: 5 cases highlighting variable clinical and molecular featuresCatherine K Gestrich, Simmi Patel, Seema M Shroff, et al.
Journal of Medicinal Chemistry|April 1, 1987
Leukotriene receptor antagonists. 1. Synthesis and structure-activity relationships of alkoxyacetophenone derivativesW S Marshall, T Goodson, G J Cullinan, et al.
Alimentary Pharmacology & Therapeutics|April 1, 1995
Colonic spreading of a non-chlorofluorocarbon mesalazine rectal foam enema in patients with quiescent ulcerative colitisI R Wilding, C J Kenyon, S Chauhan, et al.
Antisense Research and Development|January 1, 1994
Cellular pharmacology and protein binding of phosphoromonothioate and phosphorodithioate oligodeoxynucleotides: a comparative studyJ L Tonkinson, M Guvakova, Z Khaled, et al.
Biochemistry|August 24, 2005
Crystal structure of a luteoviral RNA pseudoknot and model for a minimal ribosomal frameshifting motifPradeep S Pallan, William S Marshall, Joel Harp, et al.
Neurology|May 26, 2022
Adult Neurology Rotations for Child Neurology Residents: A Survey of Program DirectorsCullen S Marshall, Stella Deng, Hannah S Jackson, et al.
Scientific Reports|August 10, 2020
Myeloid-derived suppressor cell depletion therapy targets IL-17A-expressing mammary carcinomasBassel Dawod, Jinghua Liu, Simon Gebremeskel, et al.
Neurorehabilitation and Neural Repair|August 19, 2007
Brain activity associated with stimulation therapy of the visual borderzone in hemianopic stroke patientsRandolph S Marshall, John J Ferrera, Anna Barnes, et al.
The Journal of Pharmacology and Experimental Therapeutics|April 1, 1985
LY171883, 1-less than 2-hydroxy-3-propyl-4-less than 4-(1H-tetrazol-5-yl) butoxy greater than phenyl greater than ethanone, an orally active leukotriene D4 antagonistJ H Fleisch, L E Rinkema, K D Haisch, et al.
Pageof 151